At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in ...

Infection with Japanese encephalitis virus, a mosquito-borne flavivirus, was identified in a patient who received a liver ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?

As India’s healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in screening with the lauching of Mispa i60 that offers a simple ...

Neuberg Diagnostics has introduced the Mispa i60 in Chennai for Alzheimer’s screening through a blood test. The test uses a ...

A new class of biomarker tests are able to diagnose some Alzheimer's cases. The next step would be predicting it: Here's ...

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) ...

Phase 2 TBCRC049 trial results show tucatinib triplet therapy improves survival in HER2+ breast cancer patients with ...

Scientists have discovered a new quantitative biomarker in lumbar fluid that is helping doctors to diagnose Parkinson's ...

Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value ...

Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.